Twin Capital Management Inc. Trims Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Twin Capital Management Inc. decreased its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 40,577 shares of the pharmacy operator’s stock after selling 1,549 shares during the quarter. Twin Capital Management Inc.’s holdings in Walgreens Boots Alliance were worth $1,059,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of WBA. Vontobel Holding Ltd. increased its position in Walgreens Boots Alliance by 104.6% in the first quarter. Vontobel Holding Ltd. now owns 36,922 shares of the pharmacy operator’s stock worth $1,752,000 after buying an additional 18,879 shares in the last quarter. Moors & Cabot Inc. grew its position in shares of Walgreens Boots Alliance by 31.1% during the first quarter. Moors & Cabot Inc. now owns 20,791 shares of the pharmacy operator’s stock worth $931,000 after purchasing an additional 4,931 shares in the last quarter. Sequoia Financial Advisors LLC grew its position in shares of Walgreens Boots Alliance by 27.9% during the first quarter. Sequoia Financial Advisors LLC now owns 7,569 shares of the pharmacy operator’s stock worth $339,000 after purchasing an additional 1,651 shares in the last quarter. Candriam Luxembourg S.C.A. grew its position in shares of Walgreens Boots Alliance by 0.5% during the first quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator’s stock worth $2,842,000 after purchasing an additional 310 shares in the last quarter. Finally, Baird Financial Group Inc. grew its position in shares of Walgreens Boots Alliance by 14.2% during the first quarter. Baird Financial Group Inc. now owns 467,533 shares of the pharmacy operator’s stock worth $20,932,000 after purchasing an additional 58,184 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Analyst Upgrades and Downgrades

WBA has been the subject of several research analyst reports. Leerink Partnrs reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. SVB Leerink cut their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research report on Monday, March 18th. Truist Financial reissued a “hold” rating and set a $25.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. Barclays initiated coverage on Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price target for the company. Finally, UBS Group dropped their price target on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, April 3rd. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus target price of $24.36.

Insider Transactions at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the acquisition, the director now owns 3,000 shares in the company, valued at approximately $54,150. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the acquisition, the director now owns 3,000 shares in the company, valued at approximately $54,150. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Valerie B. Jarrett purchased 4,456 shares of Walgreens Boots Alliance stock in a transaction dated Monday, January 29th. The stock was acquired at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the acquisition, the director now owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 13,456 shares of company stock worth $270,423. 17.40% of the stock is currently owned by company insiders.

Walgreens Boots Alliance Price Performance

NASDAQ:WBA opened at $17.59 on Friday. The firm has a market capitalization of $15.18 billion, a price-to-earnings ratio of -2.51, a PEG ratio of 1.09 and a beta of 0.73. Walgreens Boots Alliance, Inc. has a 1 year low of $17.51 and a 1 year high of $36.14. The business has a 50 day simple moving average of $20.50 and a 200-day simple moving average of $21.95. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. During the same period last year, the company earned $1.16 EPS. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. Equities analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.